title: A translational approach to ventilator associated pneumonia.
abstract: The management of Ventilator Associated Pneumonia (VAP) presents many difficulties because of the heterogeneity of the disease; the way the immunocompromised host and the aggressive ICU environment interact is only partially discovered, the available biomarkers for diagnosis are not sufficient to ensure prompt differentiation between sick patients and patients at risk, the microbiological cultures require invasive techniques and time consuming methods. A translational medicine and bio-informatics approach can enable the identification of the main players of pathology, which may represent novel therapeutic targets or biomarker candidates. Analysis of proteome i.e. allows to individuate proteins that act as biomarkers, for patient-centered research strategies. Similarly, the genomic approach has proved useful to individuate those patients who are prone to develop VAP, and, in the future, we could be able to immunomodulate their responses to save them from nosocomial infections.
authors.affiliation: Università di Salerno, Baronissi (SA), Italy.
authors.forename: Ornella
authors.initials: O
authors.lastname: Piazza
authors.affiliation: Fudan University, Shanghai, China ; Zhongshan Hospital, Fudan University, Shanghai, China.
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Wang
keywords: Biomarkers; Procalcitonin; Tracheobronchitis; VAP; sTREM
references.citation: Pulm Pharmacol Ther. 2014 Aug;28(2):98-108
references.pmid: 24252805
references.citation: Chest. 2008 Jul;134(1):101-8
references.pmid: 18403669
references.citation: Am J Crit Care. 2012 Nov;21(6):e110-9
references.pmid: 23117911
references.citation: Cochrane Database Syst Rev. 2011 Oct 05;(10):CD007577
references.pmid: 21975771
references.citation: Am J Respir Crit Care Med. 2014 Apr 15;189(8):947-55
references.pmid: 24498886
references.citation: Curr Opin Pulm Med. 2013 May;19(3):216-28
references.pmid: 23524477
references.citation: New Microbiol. 2009 Jul;32(3):277-83
references.pmid: 19845110
references.citation: Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S131-5
references.pmid: 20597663
references.citation: PLoS One. 2014 Jan 30;9(1):e87538
references.pmid: 24498130
references.citation: BMC Microbiol. 2012 Jun 20;12:113
references.pmid: 22716902
references.citation: Med Intensiva. 2012 May;36(4):257-63
references.pmid: 22301068
references.citation: Proteomics Clin Appl. 2008 Sep;2(9):1208-22
references.pmid: 21136918
references.citation: J Trauma Acute Care Surg. 2013 Feb;74(2):354-60; discussion 360-2
references.pmid: 23354225
references.citation: J Trauma Acute Care Surg. 2013 Feb;74(2):568-74
references.pmid: 23354252
references.citation: Tuberc Respir Dis (Seoul). 2012 Mar;72(3):293-301
references.pmid: 23227069
references.citation: Respir Care. 2012 Dec;57(12):2052-8
references.pmid: 22613763
references.citation: Cell Microbiol. 2012 Sep;14(9):1336-44
references.pmid: 22640368
references.citation: New Microbiol. 2012 Apr;35(2):199-206
references.pmid: 22707133
references.citation: Epidemiol Infect. 2013 Jun;141(6):1214-22
references.pmid: 22954403
references.citation: Heart Lung. 2013 Mar-Apr;42(2):139-45
references.pmid: 23273657
references.citation: J Hosp Infect. 2012 Jun;81(2):92-7
references.pmid: 22552164
references.citation: BMC Infect Dis. 2012 Oct 24;12:268
references.pmid: 23095664
references.citation: Electrophoresis. 1998 Aug;19(11):1853-61
references.pmid: 9740045
references.citation: Med Intensiva. 2014 Aug-Sep;38(6):337-46
references.pmid: 24035696
references.citation: Transl Med UniSa. 2012 Apr 30;3:15-21
references.pmid: 23905048
references.citation: PLoS One. 2012;7(8):e42065
references.pmid: 22916119
references.citation: PLoS One. 2013;8(3):e58782
references.pmid: 23505561
references.citation: Am Rev Respir Dis. 1991 May;143(5 Pt 1):1121-9
references.pmid: 2024824
references.citation: Curr Opin Crit Care. 2012 Oct;18(5):487-94
references.pmid: 22889869